Your session is about to expire
← Back to Search
Financial Management Support for HIV/AIDS Adherence
N/A
Waitlist Available
Led By Mary E Hawk, DrPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
English- or Spanish-speaking
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cd4 will be collected at baseline, 6-, 12-, 18-, and 24- months.
Awards & highlights
Study Summary
This trial will test the effect of Client-Centered Rep Payee, which helps PLWHA with financial management, on ART adherence and viral load.
Who is the study for?
This trial is for adults living with HIV/AIDS who speak English or Spanish, earn below 138% of the federal poverty level, and struggle with medication adherence or aren't virally suppressed. They must be receiving Social Security benefits but not currently have a Representative Payee.Check my eligibility
What is being tested?
The study tests if financial management support (Client-Centered Representative Payee) can help people with HIV/AIDS pay bills on time, reduce stress, improve housing stability, attend medical appointments more regularly, stick to their medication schedule better, and achieve lower viral loads.See study design
What are the potential side effects?
Since this intervention involves financial management rather than a drug or medical procedure, traditional side effects are not expected. However, participants may experience changes in stress levels due to alterations in their financial situation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ cd4 will be collected at baseline, 6-, 12-, 18-, and 24- months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cd4 will be collected at baseline, 6-, 12-, 18-, and 24- months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ART Adherence
Secondary outcome measures
ART Adherence
CD4
Connections with Providers
+12 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: RCT: InterventionExperimental Treatment1 Intervention
Participants in the RCT intervention arm will receive client-centered representative payee services in addition to the standard of care.
Group II: Choice InterventionExperimental Treatment1 Intervention
Participants in the Choice intervention arm will receive client-centered representative payee services in addition to the standard of care. They will not be randomly assigned.
Group III: RCT: ControlActive Control1 Intervention
Participants in the RCT control group will receive the standard of care.
Group IV: Choice ControlActive Control1 Intervention
Participants in the RCT control group will receive the standard of care. They will not be randomly assigned.
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,016 Total Patients Enrolled
University of Alabama at BirminghamOTHER
1,582 Previous Clinical Trials
2,279,938 Total Patients Enrolled
University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,250 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My HIV is not well-controlled, or I often miss my medication.I am 18 years old or older.I speak English or Spanish.You have HIV/AIDS.
Research Study Groups:
This trial has the following groups:- Group 1: RCT: Control
- Group 2: Choice Intervention
- Group 3: Choice Control
- Group 4: RCT: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an age cap on eligibility for this medical trial?
"This clinical trial stipulates that volunteers must be between 18 to 100 years old. Additionally, there are 149 trials for minors and 466 studies for seniors."
Answered by AI
Is the enrollment period for this study still open?
"According to information published on clinicaltrials.gov, this medical trial has closed recruitment and is no longer accepting new participants. It was initially posted in May 2017 with the most recent update occurring in mid-May of 2022. Despite its closure, there are 636 other trials actively recruiting volunteers at present."
Answered by AI
What are the eligibility criteria for participation in this clinical trial?
"This medical trial is enrolling 91 HIV-positive patients aged 18 to 100. To be eligible for participation, these patients must meet the following conditions: minimum age of 18 years old, income less than 138% of federal poverty level, diagnosed with HIV/AIDS and beneficiaries of Social Security entitlements (SSI or SSDI)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger